New patent expiration for Eagle Pharms drug RYANODEX
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. […]
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. […]
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 8,017,150 Expiration: Feb 13, 2023 See More … For more information on
Drug Patent Expirations for the Week of February 12, 2023 Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs.
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
Annual Drug Patent Expirations for LEXAPRO Lexapro is a drug marketed by Allergan and is included in two NDAs. It
Annual Drug Patent Expirations for NEXAVAR Nexavar is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug NEXAVAR Read Post »
NEXAVAR (sorafenib tosylate) Bayer hlthcare Patent: 8,618,141 Expiration: Feb 11, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 5, 2023 Read Post »
NEXAVAR (sorafenib tosylate) Bayer hlthcare Patent: 8,618,141 Expiration: Feb 11, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 5, 2023 Read Post »
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two
New patent expiration for Endo Pharms drug OPANA ER Read Post »
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one
Get fresh news and insights, drug patent expirations & more…